FIBROVEIN 0.2 %, solution for injection 2 bottles of 5 ml
Active ingredients: Sodium myristyl sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FIBROVEIN 0,2 %, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- STD PHARMACEUTICAL (IRELAND) (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62685543CIP72688236CIP133400926882365Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉTRADÉCYL SULFATE DE SODIUMsolution | 2 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.